Variant Synonymizer: Platform to identify mutations defined in different ways is available now!
Over 2,000 gene–disease validation summaries are now available—no login required!
Holt-Oram syndrome (HOS) is a congenital heart-hand disorder caused by heterozygous mutations in TBX5, a T-box transcription factor essential for cardiac septation and upper limb development (PMID:8988165). ClinGen classifies the TBX5–HOS association as Definitive based on over 100 unrelated patients, multi-generation familial segregation, and concordant functional data demonstrating haploinsufficiency.
HOS is inherited in an autosomal dominant manner with full penetrance. More than 108 distinct TBX5 variants have been reported in over 277 patients, including missense, nonsense, frameshift, splice-site, and intragenic duplications (PMID:38336121). Segregation analyses in large pedigrees, such as a five-generation family with a 48 kb exon 2–9 duplication in nine affected individuals, further support pathogenicity (PMID:22333898). A canonical variant, c.710G>A (p.Arg237Gln), has been repeatedly observed in HOS families and disrupts DNA binding (PMID:8988165).
Segregation studies report at least eight additional affected relatives carrying pathogenic TBX5 alleles in single families, underscoring familial cosegregation and variable expressivity (PMID:22333898).
TBX5 haploinsufficiency is the primary disease mechanism. Tbx5(+/–) mice exhibit heart septal defects and conduction abnormalities mirroring HOS (PMID:11572777). Zebrafish heartstrings mutants lacking tbx5 display pectoral fin absence and cardiomyopathy (PMID:12223419). In vitro assays demonstrate that missense mutations such as G80R and R237Q impair DNA binding, reduce synergy with NKX2-5 and GATA4, and alter nuclear localization (PMID:12499378).
Collectively, the extensive case series, robust segregation data, and concordant in vivo and in vitro functional studies meet and exceed ClinGen criteria for a Definitive gene-disease relationship. No compelling conflicting evidence has been reported.
Key Take-home: TBX5 mutational analysis is clinically actionable for definitive diagnosis of Holt-Oram syndrome and informs genetic counseling and prenatal decision-making.
Gene–Disease AssociationDefinitive
Genetic EvidenceStrong108 variants in 277 patients; autosomal dominant segregation in large pedigrees Functional EvidenceStrongMouse and zebrafish models recapitulate phenotype; in vitro assays show loss of DNA binding and disrupted interactions |